Michael Keating, MD, Oral History Interview, May 20, 2014

Michael Keating, MD, Oral History Interview, May 20, 2014

Files

Download Navigation Materials (139 KB)

Download Full Interview Transcript (353 KB)

Loading...

Media is loading
 

Description

Major topics covered:

  • The history of translational research at MD Anderson
  • The Department of Developmental Therapeutics
  • MD Anderson culture
  • Changes at MD Anderson with growth
  • The Moon Shots Program
  • Leadership at MD Anderson
  • Global Research Foundation

Identifier

KeatingM_02_20140520

Publication Date

5-20-2014

Publisher

The Historical Resources Center, Research Medical Library, The University of Texas Cancer Center

City

Houston, Texas

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Topics Covered

University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute

Disciplines

History of Science, Technology, and Medicine | Oncology | Oral History

About the Interview

About the Interview Subject:

Michael Keating, M.D. (b. 1 July 1943, Melbourne, Australia) came to MD Anderson as a Fellow in the Department of Developmental Therapeutics in 1974 and joined the faculty as an Assistant Professor in 1978. Today he is a professor of medicine in the Department of Leukemia in the Division of Cancer Medicine. Dr. Keating established his reputation with his investigations into the natural histories of chronic lymphocytic leukemia and his collaborative work on drug treatments, combination treatments, and multi-modality treatments for leukemia, a number of which became standard of care. Dr. Keating served as Associate Vice President for Patient Care in Clinical Investigations from 1990 – 1995. From 1995 to 1999 he served as Associate Head for Clinical Research in Leukemia. He is currently co-leader of the Chronic Lymphocytic Leukemia Moon Shot Program. Dr. Keating is also the Founding President and CEO of the Global Research Foundation, a non-profit organization supporting research into Chronic Lymphocytic Leukemia. The interview sessions take place in a conference room in the Department of Leukemia in the Faculty Center on the Main Campus of MD Anderson. Tacey A. Rosolowski, Ph.D. is the interviewer.

Conditions Governing Access

Redacted

Michael Keating, MD, Oral History Interview, May 20, 2014

Share

COinS